Bristol-Myers Squibb Company
Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS

Abstract:

The application provides Fc fusion proteins having novel arrangements. In one embodiment, the application provides Fc fusion proteins comprising a .sup.10Fn3 domain. In another embodiment, the application provides Fc fusion proteins comprising linkers derived from the naturally occurring C-terminal tail regions of membrane bound or secretory immunoglobulins.